Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,063,951
+$400,805 QoQ
Shares Held
8,202
+7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#1,937
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lantz Financial LLC holds $16,892,877 across 12 Drug Manufacturers - General names. ABBV ranks #5 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,860 | $3,266,054 | |
| 2 | LLY |
ELI LILLY & Co
|
2,003 | $2,402,458 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,221 | $2,212,898 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,595 | $2,096,612 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
8,202 | $2,063,951 | |
| 6 | NVS |
Novartis AG
|
7,596 | $1,190,445 | |
| 7 | PFE |
Pfizer Inc
|
46,747 | $1,125,667 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,833 | $739,437 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,063,951 | 8,202 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,663,146 | 7,647 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,726,927 | 7,558 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,790,498 | 7,733 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,349,457 | 7,270 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,466,849 | 7,001 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,183,659 | 6,661 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,273,943 | 6,451 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,081,090 | 6,303 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,192,755 | 6,550 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,174,827 | 7,581 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $999,447 | 6,705 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $901,613 | 6,692 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $1,060,129 | 6,652 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $660,176 | 4,085 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $542,879 | 4,045 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $616,469 | 4,025 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $752,190 | 4,640 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $669,282 | 4,943 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $497,712 | 4,614 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $524,113 | 4,653 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $433,096 | 4,002 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $405,455 | 3,784 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,406,082 | 16,053 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,580,894 | 16,102 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,243,877 | 16,326 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||